These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 6221530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
    Punnonen K, Uotila P, Mäntylä E.
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
    [Abstract] [Full Text] [Related]

  • 4. [Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].
    Kitamura S, Ishihara Y, Takaku F.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jan; 22(1):3-8. PubMed ID: 6539836
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M.
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [Abstract] [Full Text] [Related]

  • 6. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
    Edmonds LC, Lefer AM.
    Life Sci; 1984 Oct 22; 35(17):1763-8. PubMed ID: 6434893
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S, Taniguchi K, Wakitani K, Omawari N, Kira H, Miyamoto T, Okegawa T, Kawasaki A, Ujiie A.
    Jpn J Pharmacol; 1986 Jul 22; 41(3):393-401. PubMed ID: 3093741
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ, Nandiwada PA, Spannhake EW, Rosenson RS, McNamara DB, Hyman AL.
    Chest; 1983 May 22; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract] [Full Text] [Related]

  • 9. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T, Ogawa K, Sakai K, Watanabe J, Satake T, Kayama N, Hiraku S, Naito J.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 May 22; 11():245-51. PubMed ID: 6221531
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat].
    Nakayama D, Ikeda T.
    Nihon Jinzo Gakkai Shi; 1988 Jan 22; 30(1):79-84. PubMed ID: 3386014
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Res; 1980 Jan 22; 6():417-25. PubMed ID: 6247892
    [No Abstract] [Full Text] [Related]

  • 12. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jan 22; 11():235-40. PubMed ID: 6221529
    [No Abstract] [Full Text] [Related]

  • 13. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O, Nagatsuka K, Nakabayashi S, Isaka Y, Yoneda S, Kimura K, Abe H.
    Stroke; 1985 Jan 22; 16(2):241-4. PubMed ID: 3883580
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological manipulation of canine cyclooxygenase and thromboxane synthetase in vivo: differential renal and platelet recovery rates.
    Oshima T, McCluskey ER, Honda A, Needleman P.
    J Pharmacol Exp Ther; 1984 May 22; 229(2):598-602. PubMed ID: 6425495
    [Abstract] [Full Text] [Related]

  • 15. Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma".
    Bertelé V, Falanga A, Tomasiak M, Dejana E, Cerletti C, de Gaetano G.
    Science; 1983 Apr 29; 220(4596):517-9. PubMed ID: 6682245
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE, Lefer DJ, Lefer AM.
    Arch Int Pharmacodyn Ther; 1983 Sep 29; 265(1):76-84. PubMed ID: 6686001
    [Abstract] [Full Text] [Related]

  • 17. OKY-1581, a potential selective thromboxane synthetase inhibitor.
    Feuerstein N, Ramwell PW.
    Eur J Pharmacol; 1981 Feb 19; 69(4):533-4. PubMed ID: 7195815
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.